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dermal fibroblasts may contribute
to oral-induced tolerance against
nickelTo the Editor:
The prevalence of allergic contact dermatitis has increased
steadily with nickel (Ni) still as the main sensitizer.1,2 In this
context, it seems contradictory that orthodontic materials contain
high amounts of Ni, which lead to the inevitable release of Ni ions
(Ni21) into the oral cavity.3 However, intraoral allergic reactions
are rare and current evidence indicates that orthodontic treatment
before piercings may even prevent Ni hypersensitivity probably
via oral-induced tolerance against Ni.4 The detailed mechanisms
still remain unclear. Previous studies imply that immunological
differences between mucosal and dermal dendritic cells (DCs)
contribute to oral-induced immune tolerance.5 Thereby, mucosal
DCs display a protolerogenic character, whereas dermal DCs
have a proallergenic phenotype. Interestingly, DCs are strongly
influenced by their microenvironment determining the subse-
quent phenotype of DCs.5-7 Mediators such as transforming
growth factor (TGF)-b, IL-10, and certain innate immune
receptors such as Toll-like receptor (TLR) 4 seem to play a pivotal
role in these events.5-8
As fibroblasts primarily constitute tissue structure and are in
direct contact with immune cells such as DCs, we determined
whether dermal fibroblasts promote a proallergenic inflamma-
tory microenvironment in contrast to oral gingival (mucosal)
fibroblasts, which may favor a protolerogenic anti-
inflammatory surrounding. Therefore, primary human oral/
gingival fibroblasts (HGFs) and primary human dermal
fibroblasts (HDFs) were challenged with Ni ions (Ni21) and
subsequent cell signaling and the expression of certain media-
tors responsible for immune cell activation and recruitment
were evaluated (for details, see this article’s Online Repository
at www.jacionline.org). 2016 The Authors. Published by Elsevier Inc. on behalf of the American Academy of
Allergy, Asthma & Immunology. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Because Ni21 exerts some effects via TLR4-binding and nu-
clear factor kappa B (NF-kB) is a key regulator of inflamma-
tion,8 downstream activation of the transcription factor NF-kB
and the expression of its target gene IL-1b were investigated.
Nuclear accumulation of NF-kB was markedly induced after
Ni21 stimulation in HDFs than in HGFs (Fig 1, A). In line
with these findings, IL-1b mRNA expression was significantly
elevated in HDFs (Fig 1, B). In contrast, reduced nuclear
NF-kB levels were found in HGFs. Accordingly, Ni21 pro-
voked significantly higher expression levels of IL-1b mRNA
in dermal cells than in gingival cells (45-fold, Fig 1, B). In
good agreement with mRNA results, Ni21 challenge induced
an increase in IL-1b protein release by HDFs. Instead, in
HGFs IL-1b protein level was only slightly elevated and
significantly less compared with that in HDFs (22-fold,
Fig 1, C).
Because divalent cations such as Ni21 are known for their
hypoxia-mimicking capacities,E1,E2 we determined the activa-
tion of the transcription factor hypoxia-inducible factor (HIF)-
1a and its target gene vascular endothelial growth factor
(VEGF), which is liable for vascularization, endothelial perme-
ability, and immune cell invasion.E3,E4 Notably, HIF-1a mRNA
expression was not altered by Ni21 stimulation in HDFs or
HGFs (data not shown). However, HIF-1a activation measured
as nuclear accumulation was increased in HDFs. Similar results
were detectable in the cytoplasm of HDFs after Ni21 challenge
(data not shown). Notably, nuclear HIF-1a accumulation in
HGFs was less intense than in HDFs (Fig 1, D). Accordingly,
VEGF mRNA levels were more than twice as high in HDFs
than in HGFs, which was statistical significant (Fig 1, E).
Regarding VEGF protein, results were in line with mRNA
data because significantly higher protein levels were detected
in HDFs than in HGFs (4-fold, Fig 1, F).
To antagonize inflammatory processes, anti-inflammatory
mediators linked to the induction of immune tolerance are
secreted.E5,E6 Therefore, we investigated IL-10 and TGF-b
mRNA and protein expression after Ni21 challenge. A low
constitutive expression of IL-10 mRNA could be demonstrated
in HDFs, which was not affected by Ni21 incubation (Fig 2, A).
In contrast, in HGFs Ni21 incubation increased the expression
levels of IL-10 significantly (10-fold to 30-fold). Accordingly,
we found very low IL-10 protein levels in HDFs and signifi-
cantly higher amounts in HGF supernatants (30-fold; Fig 2,
B). Notably, TGF-b was not altered in HDFs or HGFs (data
not shown).
Next, we determined chemokine (C-C motif) ligand 20
(CCL20); macrophage inflammatory protein-3 (MIP-3a) because
of its chemoattractant and inflammatory capacities leading to DC
recruitment.E7 We could demonstrate that CCL20 mRNA was
induced 200-fold by Ni21 in HDFs (Fig 2, C). In contrast, Ni21
provoked only minor changes in HGF CCL20 expression.
Regarding CCL20 protein release, a time-dependent increase in
HDF supernatants was detectable (35-fold). In contrast, CCL20
protein concentrations in HGF supernatants were below the
detection limit (Fig 2, D).
Finally, to investigate the recruitment of DCs, amigration assay
was performed using supernatants of each fibroblast type (Fig 2,
E). Supernatants of HDFs cultured under control condition
reduced DC migration, whereas control supernatants of HGFs
induced an increase. Most interesting, supernatants of HDF chal-
lenged with Ni21 significantly stimulated DCmigration, whereas
FIG 1. Altered NF-kB and HIF-1a activation. Activation of the transcription factors NF-kB (A) and HIF-1a (D)
was determined followed by the analysis of mRNA and protein of their target genes IL-1b (B and C) and
VEGF (E and F) in dermal (HDFs) and gingival fibroblasts (HGFs) stimulated with 100 mmol/L Ni21.
Means 6 SEMs are depicted (*P < .05, **P < .01, ***P < .001).
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bition of their migration (Fig 2, E).
Taken together, increased IL-1b, CCL20, and VEGF protein
levels as well as decreased IL-10 expressions predispose to an
imbalanced inflammatory microenvironment with subsequent
immune cell recruitment and invasion in dermal tissue, which
seem to be inhibited in gingival/oral tissue. In line with present
data, previous studies demonstrated that in contrast to dermal
DCs, oral DCs respond with an increase in anti-inflammatory IL-
10 secretion following TLR4 activation, which then stimulate the
induction of regulatory T cells.6,7 Regulatory T cells are key
players for the induction of immune tolerance. Usually, activation
of TLR4 initiates a potent proinflammatory response accompa-
nied by the release of proinflammatory cytokines and chemoat-
tractants recruiting predominantly effectory T cells, which
aggravate inflammatory processes and allergic reactions.9 DCs
as antigen-presenting cells regulate the initiation of hypersensi-
tivities as they determine T-cell priming and activation. The
tolerogenic function of different subsets of DCs depends on their
maturation stage, certain ontogenics, and immunomodulatingagents. As the microenvironment of DCs seem to play a crucial
role in their maturation and fibroblasts primarily constitute the
intestinal lamina propria in which DCs reside, we hypothesize
that gingival fibroblasts contribute to their protolerogenic pheno-
type via altered NF-kB and HIF-1a regulation and subsequent
expression profile.
To conclude, present results unveil new aspects of oral-induced
tolerance and provide additional information for current
knowledge, which indicates that oral Ni21 challenge before
piercings may prevent Ni hypersensitivity.4 Accordingly, our
findings may open the door for new therapeutic approaches
solving current difficulties in allergic contact dermatitis and
oral-induced hyposensitivity.
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FIG 2. IL-10 and CCL20 expression and DCmigration. IL-10 (A and B) and CCL20 (C andD)mRNA and protein
expression was determined in dermal (HDFs) and gingival fibroblasts (HGFs) after 100 mmol/L Ni21 chal-
lenge (E). Induction of DC migration by supernatants of HDFs or HGFs was determined after 24 hours.
Means 6 SEMs are depicted (*P < .05, **P < .01, ***P < .001).
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TABLE I. Reproducibility of sputum PMN/mg and cytokine pro-
files following 2 LPS challenges
Outcome R value P value
PMN/mg postchallenge, closest 0.60 .02
PMN/mg postchallenge, farthest 0.59 .02
Delta PMN/mg prechallenge to postchallenge 0.55 .03
IL-1b (pg/mL) postchallenge 0.68 .01
IL-6 (pg/mL) postchallenge 0.83 .001
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Delta IL-8 (pg/mL) prechallenge to postchallenge 0.64 .02
Delta values represent the change in prechallenge to postchallenge values, whereasReproducibility of the inflamma-
tory response to inhaled endotoxin
in healthy volunteersnondelta values represent the postchallenge value only.To the Editor:
Inhaled endotoxin (LPS) challenge induces increases in
sputum polymorphonuclear leukocytes (PMNs), IL-1b, IL-6,
and IL-8, and as such has been used as a proof-of-concept
model to test the efficacy of anti-inflammatory treatments in
airway disease.1-3 Individual reproducibility of the inflamma-
tory response is a necessary component to further validate the
applicability of this model. Janssen et al1 reported that the cu-
mulative sputum PMN response was reproducible within
healthy individuals when assessed across 3 LPS challenges
separated by 4 weeks. However, there is notable variability in
sputum PMNs following inhaled LPS challenge but potentially
less with the cytokine response. Holz et al4 recently reported in
segmental rather than inhaled LPS challenge that cytokines
were found to be reproducible. We hypothesize that the inflam-
matory cytokines IL-1b, IL-6, or IL-8, either individually or as
part of an inflammatory biomarker panel, will have better repro-
ducibility than sputum PMNs, following multiple inhaled LPS
challenges.
To explore this hypothesis, we examined the reproducibility
of the airways inflammatory response to 2 or more low-dose
LPS challenges (20,000 endotoxin units) using sputum PMNs
and cytokines IL-1b, IL-6, and IL-8 in a group of 16 healthy
human volunteers. Each subject underwent a standardized
inhaled LPS challenge protocol at least 2 times. Reproducibility
was also assessed when 2 challenges were conducted with either
relatively short or prolonged time intervals between each
challenge. We have also sought to confirm the observation
that persons with the homozygous glutathione-S-transferase mu-
1 (GSTM1) genotype have increased PMN responses to inhaled
LPS.5
Data were obtained from 16 healthy control subjects who had
undergone more than 1 inhalation challenge with a 20,000
endotoxin unit dose of Clinical Center Reference Endotoxin at
our research center between May 2003 and August 2011.
Spirometry, endotoxin challenge, sputum induction and process-
ing, and mediator measurement have been previously
described.3,6 Statistical analysis is summarized in this article’s
Online Repository at www.jacionline.org.
Sixteen healthy volunteers (nonatopic, nonasthmatic, non-
smokers), aged 20 to 48 years (10 women, 6 men), underwent
more than 1 Clinical Center Reference Endotoxin challenge.
Thirteen also had subsequent GSTM1 genotyping. Postchal-
lenge and change in prechallenge to postchallenge (delta)
sputum PMNs/mg revealed significant reproducibility when
challenges were temporally closest together (mean, 4 weeks;
r 5 0.55; P 5 .02; Table I) and farthest apart (mean, 26 weeks;
r 5 0.60; P 5 .02; Table I). Correlation analysis forpostendotoxin and delta cytokine values revealed significant
reproducibility for IL-1b (r 5 0.68; P 5 .01), IL-6 (r 5 0.83;
P 5 .0005), and IL-8 (r 5 0.86; P 5 .0002) (postendotoxin:
Fig 1, A-C). Delta values revealed significant reproducibility
for IL-1b (r 5 0.79; P 5 .001) and IL-8 (r 5 0.64;
P 5 .016) (delta: Table I). Complete reproducibility results
for PMNs and cytokines appear in Table I.
Linear mixedmodel analysis based on data from 10 individuals
whose GSTM1 status was known (total 20 challenges) demon-
strated that the GSTM1 status was predictive of postchallenge
sputum IL-8, where GSTM1-null individuals demonstrated
increased IL-8 levels post-LPS challenge compared with
GSTM1-sufficient individuals (P 5 .05). Correlation analysis of
PMN/mg with IL-8 showed significant association (r 5 0.77,
P < .0001; Fig 1, D).
We confirm previous reports of reproducible sputum neutro-
philia1 postendotoxin challenge and also demonstrate for the first
time significant reproducibility for the proinflammatory cyto-
kines IL-8, IL-6, and IL-1b in inhaled LPS challenge. Among
all our markers of inflammation (including PMN/mg), IL-8
demonstrated the strongest reproducibility. We further demon-
strated that significant reproducibility among our inflammatory
markers was present regardless of a relatively short or prolonged
time interval between each challenge, suggesting that an individ-
ual’s responsiveness to LPS is a stable biological characteristic.
This observation has practical implications for proof- of-
concept drug development studies that require multiple endotoxin
challenges because it would alleviate the need to control for or
exclude individuals with outlying levels of prechallenge inflam-
mation. This also supports the hypothesis that LPS and other chal-
lenges can define an individual’s responsiveness to pollutants,
irrespective of minor day-to-day changes in baseline
inflammation.
IL-8 showed the strongest reproducibility of all markers
assessed in this study, suggesting that it may be a more reliable
marker of airway inflammation than neutrophil levels and may
be a preferred marker when assessing the effects of anti-
inflammatory interventions, especially across multiple study
sites. Moreover, recovery of cytokines from sputum is techni-
cally simpler and more successful than cell (neutrophil) recov-
ery because it is not dependent on total cell yield and has
minimal cell volume restrictions for analysis. The notion of an
inflammatory panel or matrix, such as IL-8, IL-6, IL-1b, and
PMN/mg, may be a more robust response metric that expands
the therapeutic capability range of an anti-inflammatory
intervention.
METHODS
Isolation of human primary gingival fibroblasts
The present study was approved by the Ethics Committee of the Medical
Faculty of the University of Bonn (Lfd. Nr 318/11). Written consent was
obtained from all patients and if necessary from their parents before inclusion.
HGFs were harvested from 9 donors who underwent extraction of wisdom
teeth. Exclusion criteria were acute or chronic inflammation or medication.
Cells were collected as previously described.E8 In brief, gingival tissues were
washed twice with PBS (Life Technologies, Darmstadt, Germany) supple-
mented with 1% antibiotic and antimycotic solution containing penicillin/
streptomycin and amphotericin B (Life Technologies). For tissue dissection,
gingiva was incubated with collagenase 2 solution (PAA Laboratories, C€olbe,
Germany) at 378C for 2.5 hours. Afterward, connective tissue was separated
from the epithelial layer and incubatedwith Dulbeccomodified Eaglemedium
culture medium supplemented with 10% FCS and 1% antibiotic and antimy-
cotic solution (all from Gibco, Life Technologies), in 378C humified atmo-
sphere of 5% CO2 in air.
HDFs were purchased from Promocell (Heidelberg, Germany) because an
elective operation to obtain dermal fibroblasts was not ethical.
Characterization of human primary gingival and
dermal fibroblasts
Human primary gingival and dermal fibroblasts were characterized before
experiments with specific mucosal and dermal markers using PCR (Table E1).
After phenotyping cell lines were cryoconserved and used for experiments at
third or fourth passage.
Cell stimulation
Initially, we determined the dose-response of both cell types with respect to
alteration in cell proliferation and viability by nickel(II)-chloride-hexahydrate
(Ni21) (Sigma-Aldrich, Taufkirchen, Germany) treatment using the Promo-
Kine XTT Cell Proliferation Kit (Promocell). Therefore, 5000 fibroblasts
per well from 3 donors were seeded in 96-well plates followed by Ni21 stim-
ulation with different concentrations (1-100,000mmol/L) for 24 hours. To pre-
vent nonspecific cell stimulation via TLR4 activation,E9 Ni21 solution was
tested for endotoxin contamination before use. After 24 hours of Ni21 stimu-
lation, XTT reaction solution was added for 2 hours followed by measurement
of absorbance at 490 nm with correction wavelength 670 nm in a microplate
reader. Ni21 concentrations below 1 mM neither affected the proliferation nor
the cell viability of fibroblasts (data not shown).
For final experiments, cells were seeded (100,000 cells/well) on 6-well
plates and grown to 80% confluence followed by stimulation with 100mmol/L
Ni21 for various time points (2, 4, 6, and 24 hours) because this concentration
was far below the lethal dose and induced the highest mRNA expression
levels. Unstimulated fibroblasts served as control. In addition, we used LPS
derived from Escherichia coli (1 mg/mL LPS E coli [Invivogen, Darmstadt,
Germany]; TLR4 agonist that generally induced a nuclear accumulation of
NF-kB), dimethyloxaloylglycine (1 mM dissolved in culture medium; inhib-
itor of prolyl hydroxylase and the asparaginyl hydroxylase factor inhibiting
HIF causing an upregulation of HIF-1a), and another divalent cation
(100 mmol/L cobalt chloride [Co21]) as positive controls for immunoblots.
RNA isolation and quantitative PCR
Fibroblasts were lysed with 4 mol guanidinthiocyanat (Roth, Karlsruhe,
Germany) and total RNA was extracted using the acid guanidinium
thiocyanate/phenol/chloroform extraction method. One microgram of total
RNA was reverse transcribed into cDNA by the use of 200 U of Maloney
Murine Leukemia Virus reverse transcriptase (Bio-Rad,Munich, Germany) as
previously described.E10,E11 cDNA expression was detected by real-time PCR
using specific TaqMan probes. Amounts of cDNA were normalized to the
housekeeping gene 18S, and cDNA expression was calculated as relative
expression of respective controls.
Whole-cell lysate preparation
For whole-cell lysate preparation, fibroblasts were lysed with 150 mL lysis
buffer (150 mM NaCl, 10 mM Tris, pH 7.9, 1 mM EDTA, 0.1% Igepal,
13 Protease Inhibitor Cocktail [Roche Diagnostics, Mannheim, Germany])
for 20 minutes on ice. Afterward, lysates were centrifuged at 3600 rpm, 48C
for 5 minutes, and supernatants containing cellular protein were collected and
stored at 2808C. Protein concentrations were quantified using the Bio-Rad
protein assay reagent (Bio-Rad).
Nuclear extract preparation
To determine activated NF-kB and HIF-1a, nuclear protein accumulation
was evaluated. Therefore, nuclear proteins were prepared using a NE-PER
nuclear extraction kit (Pierce, Rockford, Ill) following manufacturer’s
instructions. Nuclear proteins were stored at 2808C until use and protein
concentrations were determined with the Bio-Rad kit (Bio-Rad).
Immunoblots
After addition of 43 sample buffer (50 mM Tris, pH 6.8, 2% (w/v) SDS,
5% (v/v) 2-mercaptoethanol, 0.0125% bromophenol blue, and 1% glycine),
50 mg of total cell lysate or 20 mg of nuclear extract per lane was subjected to
7.5% SDS-PAGE and transferred onto a nitrocellulose membrane (0.2 mm
pore size; Schleicher & Schuell Microscience, Dassel, Germany). The
efficiency of protein transfer and equal loading was confirmed by staining
the membrane with Ponceau S (Sigma-Aldrich). Membranes were blocked
overnight at 48C with 5% (w/v) nonfat milk in TBS-T (10 mM Tris, pH 7.5,
100 mM NaCl, and 0.05% Tween-20) and washed with TBS-T before
incubation at room temperature for 2 hours with a rabbit polyclonal antibody
directed against the p65 subunit of the NF-kB complex (Santa Cruz
Biotechnology, Santa Cruz, Calif) or HIF-1a (Novus Biologicals, Littleton,
Colo). Lamin A (Abcam, Cambridge, UK) served as marker for equal protein
loading. After washing with TBS-T, horseradish peroxidase–conjugated
antirabbit IgG antibody (NewEngland Biolabs, Frankfurt amMain, Germany)
was added. Immunoreactive proteins were visualized by chemiluminescence
(Amersham Chemiluminescence Kit) and exposure to X-ray films (Agfa,
Mortsel, Belgium).
ELISAs
To investigate the release of IL-1b, VEGF, IL-10, CCL20/MIP-3a, and
TGF-b protein, cell-free supernatants were collected at the end of the
respective incubation periods and kept at 2808C until further analysis. For
the protein measurement, Quantikine ELISAs were used according to the
manufacturer’s instruction (R&D Systems, Wiesbaden, Germany).
DC isolation
Initially, PBMCs were purified from buffy coats using Ficoll-Paque density
gradient. Afterward, CD141 cells were separated by magnetic-activated cell
sorting using CD14-microbeads (Miltenyi Biotec, Bergisch Gladbach, Ger-
many) according to the manufacturer’s instructions. Then, human DCs were
isolated using the DC isolation kit (human Diamond Plasmacytoid Dendritic
Cell Isolation Kit) from Miltenyi Biotec. Afterward, DC purity (>90%) and
cell viability (dead cells < 10%) were determined by flow cytometry and try-
pan blue staining, respectively. DCs were resuspended in Gibco Advanced
RPMI 1640 supplemented with 10% heat-inactivated FCS, 13 GlutaMAX
and 100 U/mL penicillin, and 100 mg/mL streptomycin (all from Life
Technologies).
Migration assay
To evaluate DC migration, the CultureCoat BME Cell Invasion Assay
(R&D Systems) was used following manufacturer’s instructions. Briefly, DCs
were cultured in the migration chamber (inserted top chamber) of a 96-well
microplate at a density of 50,000 cells/well in 50-mL medium. To induce cell
migration, 150-mL supernatants of HDFs or HGFs preincubated with
100 mmol/L of Ni21 solution for 6 and 24 hours, respectively, were added
to the assay chamber (bottom chamber). After 24 hours of incubation with
supernatants at 378C and 5% CO2, migrated DCs in the bottom chamber
were dissociated and fluorescence labeled with Calcein AM for 1 hour
followed by measurement of excitation at 485 nm with emission at 520 nm
in a fluorescence plate reader. The induction of DCmigration via supernatants
of HGFs and HDFs was calculated in relation to DCmigration incubated with
medium only or medium containing Ni21, respectively.
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Statistical analysis
All experiments were performed in triplicate except for DC migration,
which was performed in duplicate and repeated at least 2 to 3 times.
Differences in mRNA expression between HGFs and HDFs were analyzed
by unpaired t test, whereas differences in protein levels and DC migration be-
tween control groups of HGFs and HDFs as well as each Ni21 group were
determined by 1-way ANOVA followed by Bonferroni comparison test using
GraphPad Prism 5.0 Software (GraphPad Software, La Jolla, Calif). Data are
shown as means6 SEM, and P values of less than .05 were considered to indi-
cate significance.
REFERENCES
E1. Viemann D, Schmidt M, Tenbrock K, Schmid S, M€uller V, Klimmek K, et al. The
contact allergen nickel triggers a unique inflammatory and proangiogenic gene
expression pattern via activation of NF-kappaB and hypoxia-inducible factor-
1alpha. J Immunol 2007;178:3198-207.
E2. Brant KA, Fabisiak JP. Nickel and the microbial toxin, MALP-2, stimulate proan-
giogenic mediators from human lung fibroblasts via a HIF-1alpha and COX-2-
mediated pathway. Toxicol Sci 2009;107:227-37.
E3. Brown LFSM, Olbrich B, Berse RW, Jackman G, Matsueda KA, Tognazzi EJ,
et al. Overexpression of vascular permeability factor (VPF/VEGF) and its endo-
thelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 1995;
154:2801-7.
E4. Cramer T, Yamanishi Y, Clausen BE, F€orster I, Pawlinski R, Mackman N, et al.
HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003;112:
645-57.
E5. Allam JP, W€urtzen PA, Reinartz M, Winter J, Vrtala S, Chen KW, et al. Phl p 5
resorption in human oral mucosa leads to dose-dependent and time-dependent
allergen binding by oral mucosal Langerhans cells, attenuates their maturation,
and enhances their migratory and TGF-beta1 and IL-10-producing properties.
J Allergy Clin Immunol 2010;126:638-45.
E6. Belladonna ML, Volpi C, Bianchi R, Vacca C, Orabona C, Pallotta MT, et al. Cut-
ting edge: autocrine TGF-beta sustains default tolerogenesis by IDO-competent
dendritic cells. J Immunol 2008;181:5194-8.
E7. Zhao L, Xia J, Wang X, Xu F. Transcriptional regulation of CCL20 expression.
Microbes Infect 2014;16:864-70.
E8. G€olz L, Bayer S, Keilig L, J€ager A, Stark H, G€otz W, et al. Possible implications
of Ni(II) on oral IL-1b-induced inflammatory processes. Dent Mater 2014;30:
1325-35.
E9. Schmidt M, Raghavan B, M€uller V, Vogl T, Fejer G, Tchaptchet S, et al. Crucial
role for human Toll-like receptor 4 in the development of contact allergy to
nickel. Nat Immunol 2010;11:814-9.
E10. G€olz L, Memmert S, Rath-Deschner B, J€ager A, Appel T, Baumgarten G, et al.
Hypoxia and P. gingivalis induce NFkB and HIF in PDL cells and periodontal
diseases. Mediators Inflamm 2015;2015:438085.
E11. G€olz L, Memmert S, Rath-Deschner B, J€ager A, Appel T, Baumgarten G, et al.
LPS from P. gingivalis and hypoxia increase oxidative stress in periodontal liga-
ment fibroblasts and contribute to periodontitis. Mediators Inflamm 2014;2014:
986264.
J ALLERGY CLIN IMMUNOL
VOLUME 138, NUMBER 4
LETTERS TO THE EDITOR 1205.e2
TABLE E1. Primer sequences for characterization
Gene Primer sequence (fwd/rev)
Integrin a10 fwd: AGAAAACACAGCCCAGACC
rev: TGAACCAGCCTCAATAGTCC
Collagen, type 4, alpha 1 (COL4A1) fwd: GCACAGCCAGACCATTCAGA
rev: CTATGGTGGCGAGCCAAAAG
Collagen, type 10, alpha 1 (COL10A1) fwd: AATGCCGAGTCAAATGGCCT
rev: TCAGGGGGAAGGTTTGTTGG
Osteopontin fwd: CACTCCAGTTGTCCCCACAG
rev: AACGGGGATGGCCTTGTATG
Periostin fwd: CAGCAGACACACCTGTTGGA
rev: TTGTTAGTGTGGGTCCTTCAGT
Superoxide dismutase (SOD)3 fwd: CTCTGAGGTCTCACCTTCGC
rev: AGTCTCAGGGCTTATGGGGT
TLR4 fwd: GAAGGGGTGCCTCCATTTCA
rev: GGGTCTTCTCCACCTTCTGC
Chemokine (C-X-C motif) 12 (CXCL12) fwd: TGAGCTACAGATGCCCATGC
rev: TAGCTTCGGGTCAATGCACA
Fibronectin fwd: TCTGACAGGCCTCACCAGAG
rev: GTGTAGGGGTCAAAGCACGA
fwd, Forward; rev, reverse.
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